Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

GSK Gains Vaccine Adjuvant Technology With $300 Mil. Corixa Acquisition

May 09 2005

• By The Pink Sheet

Related Content

Merck Sales Force More Focused, Not Smaller, After Vioxx Withdrawal

Dec 20 2004

Merck HPV Vaccine BLA Filing Expected In 2005, Four Years Before GSK

Dec 22 2003

SmithKline/Corixa Deal Gives SB Rights To HER-2 Breast Cancer Vaccine

Nov 02 1998

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window